secwatch / observer
8-K filed February 28, 2024, 6:59 PM ET CIK 0001838821
other material confidence high sentiment neutral materiality 0.75

ARYA Sciences shareholders approve extension of merger deadline to Apr 2, 2024, with up to 12 monthly extensions

ARYA Sciences Acquisition Corp IV

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ARYA Sciences Acquisition Corp IV: Amended articles of association to extend business combination deadline from March 2, 2024 to April 2, 2024, with optional monthly extensions up to March 2, 2025 (effective 2024-02-27).

Change
charter amendment
Effective
2024-02-27
Exact text from the filing
to approve an amendment to ARYA’s amended and restated memorandum and articles of association
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ARYA Sciences Acquisition Corp IV shareholders approved Class B Share Proposal at the 2024-02-27 meeting.

Outcome
passed
Meeting
2024-02-27
Exact text from the filing
The Class B Share Proposal For Against Abstain 6,945,870 166,682 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ARYA Sciences Acquisition Corp IV shareholders approved Redemption Limitation Amendment Proposal at the 2024-02-27 meeting.

Outcome
passed
Meeting
2024-02-27
Exact text from the filing
The Redemption Limitation Amendment Proposal For Against Abstain 6,945,870 166,682 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ARYA Sciences Acquisition Corp IV shareholders approved Extension Amendment Proposal at the 2024-02-27 meeting.

Outcome
passed
Meeting
2024-02-27
Exact text from the filing
The Extension Amendment Proposal For Against Abstain 6,903,671 208,881 0
View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR
accession 0001140361-24-010192
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.